Cellebrite DI Ltd reports results for the quarter ended June 30 - Earnings Summary
Cellebrite DI Ltd reports results for the quarter ended June 30 - Earnings Summary
Cellebrite DI Ltd CLBT.OQ reported quarterly adjusted earnings of 11 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 12 cents. The mean expectation of eight analysts for the quarter was for earnings of 11 cents per share. Wall Street expected results to range from 9 cents to 13 cents per share.
Revenue rose 15.8% to $131.14 million from a year ago; analysts expected $131.87 million.
Cellebrite DI Ltd's reported EPS for the quarter was 2 cents.
The company reported quarterly net income of $6.37 million.
Cellebrite DI Ltd shares had risen by 4.5% this quarter and lost 15.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.8% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the software peer group is also "buy"
Wall Street's median 12-month price target for Cellebrite DI Ltd is $21.00, about 27.4% above its last closing price of $15.25
This summary was machine generated from LSEG data August 13 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.11 | 0.11 | Met |
Mar. 31 2026 | 0.10 | 0.12 | Beat |
Dec. 31 2025 | 0.14 | 0.14 | Met |
Sep. 30 2025 | 0.13 | 0.14 | Beat |
Recent news on Cellebrite DI
See all newsBrief: Cellebrite Di Ltd Cellebrite Genesis Is Expanding To More Global Markets And Is Now Generally Available For Enterprise Organizations
Cellebrite DI Ltd reports results for the quarter ended June 30 - Earnings Summary
Brief: Cellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. Hogan
Israel's Cellebrite Q2 revenue slightly misses estimates
Israel's Cellebrite Q1 revenue rises 19%, beats estimates